PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth.…